Market Tracker

05/30 3:07am ET

Shire PLC (NASDAQ:SHPG)

177.18
Delayed Data
As of May 26
 -7.64 / -4.13%
Today’s Change
161.09
Today|||52-Week Range
209.22
+3.99%
Year-to-Date
Ultragenyx Receives Priority Review for rhGUS from FDA
May 24 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More
May 19 / Zacks.com - Paid Partner Content
Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug
May 22 / Zacks.com - Paid Partner Content
Sangamo's (SGMO) Hemophilia A Drug Gets Fast-Track Status
May 17 / Zacks.com - Paid Partner Content
Company News for May 19, 2017
May 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close184.82
Today’s open180.58
Day’s range176.83 - 180.91
Volume1,665,914
Average volume (3 months)1,024,369
Market cap$53.6B
Dividend yield0.51%
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-80.61%
Earnings growth (this year)+15.44%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+76.71%
P/E ratio125.7
Price/Sales3.89
Price/Book1.82

Competitors

 Today’s
change
Today’s
% change
REGNRegeneron Pharmaceut...-0.53-0.12%
AGNAllergan-1.24-0.55%
BAXBaxter International...-0.50-0.85%
ZTSZoetis Inc+0.03+0.05%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)$3.58
Annual revenue (last year)$11.3B
Annual profit (last year)$325.1M
Net profit margin5.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts